Epidemiology and Surveillance

Split Viewer

Public Health Weekly Report 2021; 14(23): 1648-1653

Published online June 3, 2021

© The Korea Disease Control and Prevention Agency

National Supporting Program for Genetic Diagnosis of Rare Diseases in Korea

Hwang Joo-Yeon, Park So Yeon, Oh Kyungwon

Division of Rare Disease Management, Bureau of Chronic Disease Prevention and Control, KDCA

In Korea, according to the Rare Disease Act of 2016, a rare disease is defined as a condition that affects fewer than 20,000 persons. Patients with a rare disease receive a misdiagnosis more than once due to low prevalence and low awareness. Patients and their families endure an unpredictable journey, also referred to as a year-long diagnostic odyssey. These rare medical conditions cause excessive medical costs and long-term social burdens.
The purpose of this report was to summarize the findings from a rare disease genetic testing diagnostic program. Using genetic diagnosis workflow, this study achieved a diagnostic rate of 39.7% in 2020 and established the need for sustainable development. Also, this study anticipates that medically actionable genetic findings may increase the diagnostic yield in undiagnosed or misdiagnosed patients.

Key words Rare disease, Ultra rare disease, Gene, Genetic diagnosis

Figure 1. Ultra rare disease according to the number of new patients in 2019

Figure 2. Distribution of agencies requesting diagnosis support by region in Korea

Figure 3. Multi-frequency genetic diagnosis diseases in 2020

Figure 4. Comparison of positive rates for diagnosis of ultra rare diseases (2019-2020)
  1. 희귀질환관리법. 법률 제17472호, 2020. 8. 11., 타법개정. 제2조..
  2. Asrul Akmal Shafie, Nathorn Chaiyakunapruk, Azuwana Supian, Jeremy Lim, Matt Zafra, Mohamed Azmi Ahmad Hassali. State of rare disease management in Southeast Asia. Orphanet J Rare Dis 2016;11:107.
    Pubmed KoreaMed CrossRef
  3. Kathleen Bogart, Veronica Irvin. Health-related quality of life among adults with diverse rare disorders. Orphanet Journal of Rare Diseases 2017;12:177.
    Pubmed KoreaMed CrossRef
  4. Soo Yeon Kim, Byung Chan Lim, Jin Sook Lee, Woo Joong Kim, Hyuna Kim, Jung Min Ko, Ki Joong Kim, Sun Ah Choi, Hunmin Kim, Hee Hwang, Ji Eun Choi, Anna Cho, Jangsup Moon, Moon Woo Seong, Sung Sup Park, Yun Jeong Lee, Young Ok Kim, Jon Soo Kim, Won Seop Kim, Young Se Kwon, June Dong Park, Younjhin Ahn, Joo-Yeon Hwang, Hyun-Young Park, Youngha Lee, Murim Choi, Jong-Hee Chae. The Korean undiagnosed diseases program: lessons from a one-year pilot project. Orphanet J Rare Dis 2019;14:68.
    Pubmed KoreaMed CrossRef
  5. 극희귀 및 상세불명 희귀, 기타염색체 이상질환 산정특례 운영지침. 2020. 1.
  6. 2019 희귀질환자 통계 연보, 국가승인통계 승인번호 제 117106호. 2020. 12.

Epidemiology and Surveillance

Public Health Weekly Report 2021; 14(23): 1648-1653

Published online June 3, 2021

Copyright © The Korea Disease Control and Prevention Agency.

National Supporting Program for Genetic Diagnosis of Rare Diseases in Korea

Hwang Joo-Yeon, Park So Yeon, Oh Kyungwon

Division of Rare Disease Management, Bureau of Chronic Disease Prevention and Control, KDCA

Abstract

In Korea, according to the Rare Disease Act of 2016, a rare disease is defined as a condition that affects fewer than 20,000 persons. Patients with a rare disease receive a misdiagnosis more than once due to low prevalence and low awareness. Patients and their families endure an unpredictable journey, also referred to as a year-long diagnostic odyssey. These rare medical conditions cause excessive medical costs and long-term social burdens.
The purpose of this report was to summarize the findings from a rare disease genetic testing diagnostic program. Using genetic diagnosis workflow, this study achieved a diagnostic rate of 39.7% in 2020 and established the need for sustainable development. Also, this study anticipates that medically actionable genetic findings may increase the diagnostic yield in undiagnosed or misdiagnosed patients.

Keywords: Rare disease, Ultra rare disease, Gene, Genetic diagnosis

Body

Figure 1. Ultra rare disease according to the number of new patients in 2019

Figure 2. Distribution of agencies requesting diagnosis support by region in Korea

Figure 3. Multi-frequency genetic diagnosis diseases in 2020

Figure 4. Comparison of positive rates for diagnosis of ultra rare diseases (2019-2020)

Fig 1.

Figure 1.Ultra rare disease according to the number of new patients in 2019
Public Health Weekly Report 2021; 14: 1648-1653

Fig 2.

Figure 2.Distribution of agencies requesting diagnosis support by region in Korea
Public Health Weekly Report 2021; 14: 1648-1653

Fig 3.

Figure 3.Multi-frequency genetic diagnosis diseases in 2020
Public Health Weekly Report 2021; 14: 1648-1653

Fig 4.

Figure 4.Comparison of positive rates for diagnosis of ultra rare diseases (2019-2020)
Public Health Weekly Report 2021; 14: 1648-1653

References

  1. 희귀질환관리법. 법률 제17472호, 2020. 8. 11., 타법개정. 제2조..
  2. Asrul Akmal Shafie, Nathorn Chaiyakunapruk, Azuwana Supian, Jeremy Lim, Matt Zafra, Mohamed Azmi Ahmad Hassali. State of rare disease management in Southeast Asia. Orphanet J Rare Dis 2016;11:107.
    Pubmed KoreaMed CrossRef
  3. Kathleen Bogart, Veronica Irvin. Health-related quality of life among adults with diverse rare disorders. Orphanet Journal of Rare Diseases 2017;12:177.
    Pubmed KoreaMed CrossRef
  4. Soo Yeon Kim, Byung Chan Lim, Jin Sook Lee, Woo Joong Kim, Hyuna Kim, Jung Min Ko, Ki Joong Kim, Sun Ah Choi, Hunmin Kim, Hee Hwang, Ji Eun Choi, Anna Cho, Jangsup Moon, Moon Woo Seong, Sung Sup Park, Yun Jeong Lee, Young Ok Kim, Jon Soo Kim, Won Seop Kim, Young Se Kwon, June Dong Park, Younjhin Ahn, Joo-Yeon Hwang, Hyun-Young Park, Youngha Lee, Murim Choi, Jong-Hee Chae. The Korean undiagnosed diseases program: lessons from a one-year pilot project. Orphanet J Rare Dis 2019;14:68.
    Pubmed KoreaMed CrossRef
  5. 극희귀 및 상세불명 희귀, 기타염색체 이상질환 산정특례 운영지침. 2020. 1.
  6. 2019 희귀질환자 통계 연보, 국가승인통계 승인번호 제 117106호. 2020. 12.

Share

  • line

Related articles

PHWR